title: Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.
authors.affiliation: Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London.
authors.forename: Yan
authors.initials: Y
authors.lastname: Beauverd
authors.affiliation: Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London.
authors.forename: Deepti
authors.initials: D
authors.lastname: Radia
authors.affiliation: Department of Haematology, St James's University Hospital, Leeds, UK.
authors.forename: Catherine
authors.initials: C
authors.lastname: Cargo
authors.affiliation: Institute of Cancer & Genetics, School of Medicine, Cardiff University, UK.
authors.forename: Steve
authors.initials: S
authors.lastname: Knapper
authors.affiliation: Department of Haematology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
authors.forename: Mark
authors.initials: M
authors.lastname: Drummond
authors.affiliation: Department of Haematology, Countess of Chester Hospital, UK.
authors.forename: Arvind
authors.initials: A
authors.lastname: Pillai
authors.affiliation: Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London.
authors.forename: Claire
authors.initials: C
authors.lastname: Harrison
authors.affiliation: Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London Susan.Robinson@gstt.nhs.uk.
authors.forename: Susan
authors.initials: S
authors.lastname: Robinson
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000009:adverse effects; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D013920:Thrombocythemia, Essential / Q000097:blood / Q000188:drug therapy*
chemical_list: D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a
keywords: essential thrombocythemia; outcomes; pegylated interferon; pregnancy; safety
references.citation: Eur J Haematol. 2009 May;82(5):350-3
references.pmid: 19243425
references.citation: Mayo Clin Proc. 2001 Jan;76(1):22-8
references.pmid: 11155408
references.citation: Cancer. 2006 Jun 1;106(11):2397-405
references.pmid: 16639737
references.citation: Blood. 2007 Jul 15;110(2):485-9
references.pmid: 17426257
references.citation: Haematologica. 2015 Nov;100(11):e443-5
references.pmid: 26250575
references.citation: Haematologica. 2005 Oct;90(10 ):1333-8
references.pmid: 16219569
references.citation: Am J Hematol. 2009 Oct;84(10):636-40
references.pmid: 19705431
references.citation: Am J Obstet Gynecol. 2005 Mar;192(3):922-3
references.pmid: 15746692
references.citation: Blood Rev. 2008 Sep;22(5):235-45
references.pmid: 18617299
references.citation: Reprod Toxicol. 2007 Nov-Dec;24(3-4):414-6
references.pmid: 17698320
references.citation: Eur J Haematol. 2014 Apr;92(4):289-97
references.pmid: 24372927
references.citation: Haematologica. 2012 Oct;97(10 ):1570-3
references.pmid: 22419578
references.citation: Ceylon Med J. 2015 Jun;60(2):72-3
references.pmid: 26132192
references.citation: Br J Haematol. 2010 May;149(3):352-75
references.pmid: 20331456
references.citation: Intern Med J. 2015 Mar;45(3):358-9
references.pmid: 25735582
references.citation: Leuk Lymphoma. 1996 Sep;22 Suppl 1:135-42
references.pmid: 8951784